Filing Details
- Accession Number:
- 0001104659-20-115850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-19 09:00:15
- Reporting Period:
- 2020-10-15
- Accepted Time:
- 2020-10-19 09:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513856 | Neurotrope Inc. | NTRP | Pharmaceutical Preparations (2834) | 463522381 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1524858 | Joshua Silverman | C/O Neurotrope, Inc. 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-15 | 50,000 | $1.07 | 50,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.04 to $1.09, inclusive. The reporting person undertakes to provide to Neurotrope, Inc., any security holder of Neurotrope, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
